EXPLORE A TOPIC
Research and resources to help you take a closer look.
The resource library
40 resourcesThis resource examines how the foundational MOTS-c study applied extracellular acidification rate (ECAR) measurements to assess glycolytic flux in cell models, detailing the methodology, findings, and limitations. It distinguishes in vitro results from broader clinical implications and highlights the mechanistic context of MOTS-c’s metabolic actions.
This resource examines the role of the folic acid rescue test in MOTS-c cellular experiments, focusing on mechanistic findings, experimental design, and the interpretation of results within the context of current peptide research. Evidence is drawn from controlled in vitro studies, with limitations and uncertainties clearly stated.
This resource examines the role of skeletal muscle endpoints in the study of MOTS-c, a mitochondrial-derived peptide, focusing on mechanistic, cellular, and animal model evidence. It details how skeletal muscle measurements inform our understanding of MOTS-c’s metabolic actions, highlights experimental methods, and discusses the limitations and uncertainties of current research.
Peptide receptor selectivity experiments are foundational in peptide research, enabling the characterization of peptide-receptor interactions, specificity, and potential off-target effects. This article explains the principles, methodologies, and interpretive frameworks for these experiments, drawing on current evidence and highlighting key limitations.
Explore Semax copper-binding and oxidative-stress experiments, what the biochemical and cell assays measured, and what they cannot establish about human health.
Learn what a primary MOTS-c study found about metabolic signaling in cells and mice, including AMPK pathways and limits of translation to people.
Review BPC-157 musculoskeletal research, the balance of animal and human evidence, and the safety gaps identified by a systematic review.
Explore TB-500 identity and metabolism studies, how the studied fragment differs from thymosin beta-4, and why laboratory findings do not prove human benefits.
Learn to assess peptide studies: controls, cell and animal models, measured outcomes and gene-expression findings, with a qualified GHK-Cu example.
Understand peptide half-life, degradation and elimination, how these differ from biological effect duration, and how to interpret study limitations.
Compare GHK and its copper complex, GHK-Cu. Learn what the cited laboratory and animal studies show, and why they do not establish human benefits.
Therapeutic peptide development requires rigorous evaluation of stability, selectivity, delivery, and manufacturing. This review details the scientific approaches used to assess these properties, distinguishing between approved medicines and research-use products. We examine analytical, biochemical, and technological strategies, highlight advances and limitations, and clarify the boundaries between research findings and clinical application.
